Skip to main navigation Skip to search Skip to main content

RASopathies

  • Lisa M. Vincent
  • , Karen W. Gripp
  • , Heather Mason-Suares
  • Children's National Medical Center
  • Partners HealthCare

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The autosomal dominant RASopathies are a group of phenotypically related developmental disorders that result from gain-of-function pathogenic variants in genes of the Ras/MAPK pathway. These fully penetrant disorders can present with variable expressivity and severity even among patients with the same pathogenic variant. Therefore, a molecular diagnosis crucial to supporting a clinical diagnosis of these disorders. Classifying variants in RASopathy genes commonly utilize only a particular subset of ACMG-AMP criteria. Key evidence for classifications include minor allele frequencies in the general population, number of affected individuals, segregation in affected family members, and de novo occurrences of the variant. This chapter illustrates how to use and adjust the strength of ACMG-AMP criteria to provide accurate and uniform classifications of variants observed in association with the RASopathies.

Original languageEnglish
Title of host publicationClinical DNA Variant Interpretation
Subtitle of host publicationTheory and Practice: A Volume in Translational and Applied Genomics
PublisherElsevier
Pages389-398
Number of pages10
ISBN (Electronic)9780128205198
DOIs
StatePublished - 1 Jan 2021

Keywords

  • Autosomal dominant
  • Gain-of-function
  • Noonan
  • RASopathy
  • Ras/MAPK

Fingerprint

Dive into the research topics of 'RASopathies'. Together they form a unique fingerprint.

Cite this